{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:01:15Z","timestamp":1784649675964,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":101,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10017-1","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:53:19Z","timestamp":1775929999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal glycosylation of MUC20 mediates TAM polarization and promotes immune escape in colorectal cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Yingru","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9487-7651","authenticated-orcid":false,"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3596-8985","authenticated-orcid":false,"given":"Xiaobei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4605-5174","authenticated-orcid":false,"given":"Wanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"10017_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA: a cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA: a cancer J. Clin."},{"key":"10017_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/338170a0","volume":"338","author":"D Vestweber","year":"1989","unstructured":"Vestweber, D. & Schatz, G. DNA-protein conjugates can enter mitochondria via the protein import pathway. Nature 338, 170\u2013172 (1989).","journal-title":"Nature"},{"key":"10017_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102135","volume":"92","author":"C Antoniotti","year":"2021","unstructured":"Antoniotti, C. et al. Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm. Cancer Treat. Rev. 92, 102135 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"10017_CR4","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA: a cancer J. Clin. 73, 233\u2013254 (2023).","journal-title":"CA: a cancer J. Clin."},{"key":"10017_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00268-007-9285-y","volume":"32","author":"M Arru","year":"2008","unstructured":"Arru, M. et al. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J. Surg. 32, 93\u2013103 (2008).","journal-title":"World J. Surg."},{"key":"10017_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"10017_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan, Y., Yu, Y., Wang, X. & Zhang, T. Tumor-associated macrophages in tumor immunity. Front. Immunol. 11, 583084 (2020).","journal-title":"Front. Immunol."},{"key":"10017_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459.e429 (2020).","journal-title":"Cell"},{"key":"10017_CR9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.7150\/ijbs.29836","volume":"15","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Elevated CD163(+)\/CD68(+) ratio at tumor invasive front is closely associated with aggressive phenotype and poor prognosis in colorectal cancer. Int. J. Biol. Sci. 15, 984\u2013998 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"10017_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-016-0269-9","volume":"23","author":"J Jen","year":"2016","unstructured":"Jen, J. & Wang, Y. C. Zinc finger proteins in cancer progression. J. Biomed. Sci. 23, 53 (2016).","journal-title":"J. Biomed. Sci."},{"key":"10017_CR11","first-page":"1097","volume":"34","author":"Q Ye","year":"2019","unstructured":"Ye, Q., Liu, J. & Xie, K. Zinc finger proteins and regulation of the hallmarks of cancer. Histol. Histopathol. 34, 1097\u20131109 (2019).","journal-title":"Histol. Histopathol."},{"key":"10017_CR12","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1111\/jcmm.14290","volume":"23","author":"V Verma","year":"2019","unstructured":"Verma, V., Paek, A. R., Choi, B. K., Hong, E. K. & You, H. J. Loss of zinc-finger protein 143 contributes to tumour progression by interleukin-8-CXCR axis in colon cancer. J. Cell. Mol. Med. 23, 4043\u20134053 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"10017_CR13","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. The OGT-c-Myc-PDK2 axis rewires the TCA cycle and promotes colorectal tumor growth. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-024-01315-4 (2024).","DOI":"10.1038\/s41418-024-01315-4"},{"key":"10017_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2022.11.018","volume":"164","author":"J Krug","year":"2023","unstructured":"Krug, J. et al. N-glycosylation regulates intrinsic IFN-\u03b3 resistance in colorectal cancer: implications for immunotherapy. Gastroenterology 164, 392\u2013406.e395 (2023).","journal-title":"Gastroenterology"},{"key":"10017_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540\u2013555 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"10017_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1025815113599","volume":"23","author":"JC Byrd","year":"2004","unstructured":"Byrd, J. C. & Bresalier, R. S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23, 77\u201399 (2004).","journal-title":"Cancer Metastasis Rev."},{"key":"10017_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cellimm.2018.03.007","volume":"333","author":"JG Rodrigues","year":"2018","unstructured":"Rodrigues, J. G. et al. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis. Cell. Immunol. 333, 46\u201357 (2018).","journal-title":"Cell. Immunol."},{"key":"10017_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-018-0994-x","volume":"37","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. LINC01296\/miR-26a\/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K\/AKT pathway. J. Exp. Clin. cancer Res. 37, 316 (2018). CR.","journal-title":"J. Exp. Clin. cancer Res."},{"key":"10017_CR19","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1038\/s41388-018-0403-0","volume":"37","author":"ST Chen","year":"2018","unstructured":"Chen, S. T. et al. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF\/MET pathway. Oncogene 37, 6041\u20136053 (2018).","journal-title":"Oncogene"},{"key":"10017_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1632-2","volume":"16","author":"N Jonckheere","year":"2018","unstructured":"Jonckheere, N. & Van Seuningen, I. Integrative analysis of the cancer genome atlas and Cancer Cell Lines Encyclopedia large-scale genomic databases: MUC4\/MUC16\/MUC20 signature is associated with poor survival in human carcinomas. J. Transl. Med. 16, 259 (2018).","journal-title":"J. Transl. Med."},{"key":"10017_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ygyno.2012.12.012","volume":"128","author":"CH Chen","year":"2013","unstructured":"Chen, C. H. et al. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer. Gynecol. Oncol. 128, 560\u2013567 (2013).","journal-title":"Gynecol. Oncol."},{"key":"10017_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-151","volume":"11","author":"X Xiao","year":"2013","unstructured":"Xiao, X. et al. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer. J. Transl. Med. 11, 151 (2013).","journal-title":"J. Transl. Med."},{"key":"10017_CR23","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00262-022-03364-5","volume":"72","author":"F Zhao","year":"2023","unstructured":"Zhao, F. et al. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma. Cancer Immunol. Immunother. 72, 1835\u20131851 (2023). CII.","journal-title":"Cancer Immunol. Immunother."},{"key":"10017_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10555-018-09775-0","volume":"38","author":"R Bhatia","year":"2019","unstructured":"Bhatia, R. et al. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Rev. 38, 223\u2013236 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"10017_CR25","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1172\/JCI65899","volume":"124","author":"C Jandus","year":"2014","unstructured":"Jandus, C. et al. Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.  J. Clin. Investig. 124, 1810\u20131820 (2014).","journal-title":"J. Clin. Investig."},{"key":"10017_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/emboj.2013.79","volume":"32","author":"C Steentoft","year":"2013","unstructured":"Steentoft, C. et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.  EMBO J. 32, 1478\u20131488 (2013).","journal-title":"EMBO J."},{"key":"10017_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-021-00569-4","volume":"19","author":"K Ganesh","year":"2022","unstructured":"Ganesh, K. Optimizing immunotherapy for colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 19, 93\u201394 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10017_CR28","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752.e4720 (2021).","journal-title":"Cell"},{"key":"10017_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello, D. V. F. et al. TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554, 538\u2013543 (2018).","journal-title":"Nature"},{"key":"10017_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 12, 134\u2013153 (2022).","journal-title":"Cancer Discov."},{"key":"10017_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","volume":"52","author":"PS Hegde","year":"2020","unstructured":"Hegde, P. S. & Chen, D. S. Top 10 Challenges in Cancer Immunotherapy. Immunity 52, 17\u201335 (2020).","journal-title":"Immunity"},{"key":"10017_CR32","doi-asserted-by":"publisher","unstructured":"Lee, J. C. et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.aba0759 (2020).","DOI":"10.1126\/sciimmunol.aba0759"},{"key":"10017_CR33","doi-asserted-by":"publisher","unstructured":"Zhu, X. et al. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. J. Immunother. Cancer 10, https:\/\/doi.org\/10.1136\/jitc-2021-004219 (2022).","DOI":"10.1136\/jitc-2021-004219"},{"key":"10017_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0747-z","volume":"17","author":"Y Cheng","year":"2018","unstructured":"Cheng, Y. et al. PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1\/2 pathway. Mol. Cancer 17, 13 (2018).","journal-title":"Mol. Cancer"},{"key":"10017_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj7002","volume":"8","author":"S Kamerkar","year":"2022","unstructured":"Kamerkar, S. et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Sci. Adv. 8, eabj7002 (2022).","journal-title":"Sci. Adv."},{"key":"10017_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107126","volume":"202","author":"Q Lv","year":"2024","unstructured":"Lv, Q. et al. CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer. Pharmacol. Res. 202, 107126 (2024).","journal-title":"Pharmacol. Res."},{"key":"10017_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","volume":"13","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J. Hematol. Oncol. 13, 156 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"10017_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304222","volume":"11","author":"Y Feng","year":"2024","unstructured":"Feng, Y. et al. The Uridylyl Transferase TUT7-Mediated Accumulation of Exosomal miR-1246 Reprograms TAMs to Support CRC Progression. Adv. Sci. 11, e2304222 (2024).","journal-title":"Adv. Sci."},{"key":"10017_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41392-021-00825-8","volume":"6","author":"W Li","year":"2021","unstructured":"Li, W., Li, F., Zhang, X., Lin, H. K. & Xu, C. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. Signal Transduct. Target. Ther. 6, 422 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10017_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10555-021-10015-1","volume":"41","author":"WE Bindeman","year":"2022","unstructured":"Bindeman, W. E. & Fingleton, B. Glycosylation as a regulator of site-specific metastasis. Cancer Metastasis Rev. 41, 107\u2013129 (2022).","journal-title":"Cancer Metastasis Rev."},{"key":"10017_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/ni.3552","volume":"17","author":"R Beatson","year":"2016","unstructured":"Beatson, R. et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat. Immunol. 17, 1273\u20131281 (2016).","journal-title":"Nat. Immunol."},{"key":"10017_CR42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/gcc.21998","volume":"51","author":"ML Poeta","year":"2012","unstructured":"Poeta, M. L. et al. Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. Genes Chromosomes Cancer 51, 1133\u20131143 (2012).","journal-title":"Genes Chromosomes Cancer"},{"key":"10017_CR43","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.1158\/1078-0432.CCR-05-1006","volume":"11","author":"WS Chen","year":"2005","unstructured":"Chen, W. S., Chang, H. Y., Li, C. P., Liu, J. M. & Huang, T. S. Tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis. Clin. Cancer Res. 11, 8615\u20138622 (2005).","journal-title":"Clin. Cancer Res."},{"key":"10017_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","volume":"124","author":"C Dobie","year":"2021","unstructured":"Dobie, C. & Skropeta, D. Insights into the role of sialylation in cancer progression and metastasis. Br. J. Cancer 124, 76\u201390 (2021).","journal-title":"Br. J. Cancer"},{"key":"10017_CR45","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/2326-6066.CIR-22-0366","volume":"10","author":"H L\u00e4ubli","year":"2022","unstructured":"L\u00e4ubli, H., Nalle, S. C. & Maslyar, D. Targeting the siglec-sialic acid immune axis in cancer: current and future approaches. Cancer Immunol. Res. 10, 1423\u20131432 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"10017_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj1270","volume":"14","author":"MA Stanczak","year":"2022","unstructured":"Stanczak, M. A. et al. Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. Sci. Transl. Med. 14, eabj1270 (2022).","journal-title":"Sci. Transl. Med."},{"key":"10017_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21550-4","volume":"12","author":"E Rodriguez","year":"2021","unstructured":"Rodriguez, E. et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat. Commun. 12, 1270 (2021).","journal-title":"Nat. Commun."},{"key":"10017_CR48","doi-asserted-by":"publisher","first-page":"D19","DOI":"10.1093\/nar\/gkq1019","volume":"39","author":"R Leinonen","year":"2011","unstructured":"Leinonen, R., Sugawara, H. & Shumway, M. The sequence read archive. Nucleic Acids Res. 39, D19\u2013D21 (2011).","journal-title":"Nucleic Acids Res."},{"key":"10017_CR49","doi-asserted-by":"publisher","first-page":"D33","DOI":"10.1093\/nar\/gkad1044","volume":"52","author":"EW Sayers","year":"2024","unstructured":"Sayers, E. W. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 52, D33\u2013d43 (2024).","journal-title":"Nucleic Acids Res."},{"key":"10017_CR50","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013d1217 (2019).","journal-title":"Nucleic Acids Res."},{"key":"10017_CR51","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 50, D1522\u2013d1527 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10017-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:02:00Z","timestamp":1784646120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10017-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10017"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10017-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"997"}}